SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination
SciSparc Ltd TEL AVIV, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”),…
#EuropeSays #Japan #JP #Japanese #Japanesepatent #Japanesepatentcoverage #JapanesePatentOffice #NeuroTheraLabsInc. #pharmaceuticalcompany #pharmaceuticaldevelopments #proprietarycombination #SciSparcLtd #theCompany
https://www.europesays.com/japan/73147/